Approved only for use in adults,
pazopanib (
Votrient®) is prescribed to help treat advanced renal cell carcinoma, the most common type of
kidney cancer. It is also approved to treat advanced soft tissue sarcoma, a type of cancer of soft tissues, such as muscle, blood vessels, nerves, and fat. However, there are times when a healthcare provider may prescribe this drug for an
off-label (unapproved) use. For example, pazopanib can be prescribed off-label to treat
thyroid cancer.
This medicine works by blocking an enzyme in the body that tells cancer cells to grow and divide. By blocking this enzyme, pazopanib can help slow down the growth of cancer cells.
(For more details on using this drug for thyroid cancer, click What Is Pazopanib Used For?. This article provides more information on how this medicine works, whether it is safe for use in older adults, and other off-label uses.)
HealthSavvy Sign In
|